SHARE-BASED COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended |
Jan. 29, 2017 | Jan. 31, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Date and terms of plan modification | In March 2016, shareholders approved a new equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. | |
Maximum number of shares of common stock that may be issued (in shares) | 4,000,000 | |
Share-based compensation costs incurred | $ 900 | $ 900 |
Cash received from option exercises | 1,000 | 2,000 |
Share-based compensation cost capitalized | 0 | 0 |
Income tax benefits realized from stock option exercises | $ 0 | $ 0 |
Stock Options [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Contractual term | 10 years | |
Period for recognition of compensation cost not yet recognized | 2 years 7 months 6 days | |
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract] | | |
Volatility | 32.20% | 49.90% |
Risk free rate of return | 1.90% | 1.70% |
Dividend yield | 0.00% | 0.00% |
Expected term | 5 years | 5 years 1 month 6 days |
Outstanding and exercisable option awards [Abstract] | | |
Outstanding at end of period (in shares) | 3,676,160 | |
Exercisable at end of period (in shares) | 2,329,981 | |
Share options granted (in shares) | 338,750 | 579,250 |
Weighted Average Exercise Price [Abstract] | | |
Weighted average exercise price, Outstanding at end of period (in dollar per share) | $ 7.97 | |
Weighted average exercise price, Exercisable at end of period (in dollar per share) | $ 6.53 | |
Stock options, additional disclosures [Abstract] | | |
Weighted average remaining contractual life, Outstanding at end of period | 6 years 6 months | |
Weighted average remaining contractual life, Exercisable at end of period | 5 years 3 months 18 days | |
Aggregate intrinsic value, Outstanding at end of period | $ 13,828 | |
Aggregate intrinsic value, Exercisable at end of period | $ 12,017 | |
Weighted-average grant date fair value of options granted (in dollar per share) | $ 3.60 | $ 4.66 |
Unrecognized compensation cost related to unvested option awards | $ 4,800 | |
Stock Options [Member] | Minimum [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Award vesting period | 1 year | |
Stock Options [Member] | Maximum [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Award vesting period | 4 years | |
Restricted Stock [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Period for recognition of compensation cost not yet recognized | 3 years 7 months 6 days | |
Restricted Stock [Abstract] | | |
Restricted stock awards granted (in shares) | 260,000 | 115,225 |
Weighted average grant date fair value of restricted stock awards (in dollar per share) | $ 11.35 | $ 12.13 |
Compensation cost not yet recognized related to unvested restricted stock awards | $ 3,500 | |
Number of shares of restricted stock outstanding (in shares) | 344,569 | |
Restricted Stock [Member] | Minimum [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Award vesting period | 1 year | |
Restricted Stock [Member] | Maximum [Member] | | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | | |
Award vesting period | 4 years | |